Caribou Biosciences, Inc. (CRBU)
1.66
-0.10
(-5.68%)
USD |
NASDAQ |
Aug 26, 14:25
Caribou Biosciences Price : 1.66 for Aug. 26, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 1.65 | 1.76 | 1.65 | 1.76 | 1.380M |
| Aug 24, 2026 | 1.68 | 1.69 | 1.61 | 1.64 | 762660.0 |
| Aug 21, 2026 | 1.64 | 1.69 | 1.615 | 1.66 | 1.162M |
| Aug 20, 2026 | 1.64 | 1.65 | 1.58 | 1.61 | 892577.0 |
| Aug 19, 2026 | 1.60 | 1.66 | 1.58 | 1.64 | 1.570M |
| Aug 18, 2026 | 1.56 | 1.58 | 1.525 | 1.56 | 557675.0 |
| Aug 17, 2026 | 1.57 | 1.59 | 1.55 | 1.57 | 952143.0 |
| Aug 14, 2026 | 1.61 | 1.61 | 1.52 | 1.58 | 1.189M |
| Aug 13, 2026 | 1.72 | 1.72 | 1.60 | 1.61 | 1.143M |
| Aug 12, 2026 | 1.69 | 1.71 | 1.66 | 1.70 | 717444.0 |
| Aug 11, 2026 | 1.68 | 1.71 | 1.65 | 1.69 | 995207.0 |
| Aug 10, 2026 | 1.65 | 1.676 | 1.63 | 1.66 | 760170.0 |
| Aug 07, 2026 | 1.65 | 1.67 | 1.625 | 1.65 | 806039.0 |
| Aug 06, 2026 | 1.61 | 1.68 | 1.59 | 1.64 | 1.059M |
| Aug 05, 2026 | 1.59 | 1.66 | 1.58 | 1.61 | 1.116M |
| Aug 04, 2026 | 1.50 | 1.58 | 1.50 | 1.57 | 1.336M |
| Aug 03, 2026 | 1.47 | 1.50 | 1.425 | 1.50 | 1.391M |
| Jul 31, 2026 | 1.53 | 1.53 | 1.43 | 1.46 | 1.128M |
| Jul 30, 2026 | 1.48 | 1.525 | 1.45 | 1.51 | 916461.0 |
| Jul 29, 2026 | 1.50 | 1.51 | 1.44 | 1.47 | 1.300M |
| Jul 28, 2026 | 1.60 | 1.60 | 1.47 | 1.49 | 1.962M |
| Jul 27, 2026 | 1.60 | 1.65 | 1.58 | 1.59 | 731616.0 |
| Jul 24, 2026 | 1.62 | 1.64 | 1.57 | 1.57 | 946834.0 |
| Jul 23, 2026 | 1.62 | 1.65 | 1.60 | 1.63 | 824433.0 |
| Jul 22, 2026 | 1.65 | 1.67 | 1.63 | 1.66 | 1.020M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 13.19 |
| Vir Biotechnology, Inc. | 10.69 |
| Arrowhead Pharmaceuticals, Inc. | 89.53 |
| Oncolytics Biotech, Inc. | 0.8551 |
| Sangamo Therapeutics, Inc. | 0.1489 |
Price Related Metrics
| PS Ratio | 15.91 |
| Price to Book Value | 1.794 |
| Earnings Yield | -64.92% |
| Market Cap | 175.95M |